chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Since after the vaccination, there has been a small area of subcutaneous induration, non tender, not warm. not erythematous but it has remained pruritic since then.
Said she didn't feel good, then fainted, falling out of her chair. Hit her head on chair in front of her as she fell to floor.
Patient was due for Hep B vaccine.  Hep A was given in error.  Patient denies any adverse symptoms.
Febrile seizure 1 day after receiving vaccines. Fever persisted for several days afterwards, suggesting a viral illness.
Temp 103. Redness and swelling (R) deltoid area extending approximately 6 inches down (R) arm was seen in ER and prescribed KEFLEX 500mg bid and Clindamycin 300mg qid.
Red, swollen, tender and hot and pain about 3 inches long and 1 inch wide at site of injection
Metallic taste/numbing soapy-like taste; This spontaneous case was reported by a consumer and describes the occurrence of DYSGEUSIA (Metallic taste/numbing soapy-like taste) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 08-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 11-Mar-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced DYSGEUSIA (Metallic taste/numbing soapy-like taste). At the time of the report, DYSGEUSIA (Metallic taste/numbing soapy-like taste) outcome was unknown.            The patient took the second dose of the mRNA-1273, hence action taken with the vaccine in response to the events was not applicable.   No concomitant medication was reported.  No treatment medication was reported.
Date of start of drug 18Dec2020/ Date of start of drug 12Jan2021; Date of start of drug 18Dec2020/ Date of start of drug 12Jan2021; Dizziness; nausea; fever; joint pain; body aches; throbbing headache x 24 hours; This is a spontaneous report from a contactable Nurse (patient). A 26-year-old female patient received BNT162b2 BNT162b2 (lot number: EL3246) second dose on 12Jan2021 on Right Arm at single dose for covid-19 immunization. Medical history included Headaches of an unknown origin. Concomitant medications were not reported. No covid prior vaccination. No covid tested post vaccination. No Known allergies. Facility type vaccine was Workplace clinic. No other vaccine in four weeks. Patient is not pregnant. The patient previously took BNT162b2 (lot number: EL0140) first dose on 18Dec2020 12:00 PM (age 26-year-old) Intramuscular on left arm at single dose for covid-19 immunization and experienced Sore arm, joint pain that started in the left elbow and moved down to the wrist/hand and eventually joint pain and body aches all over for the next 2 days. For 2nd shot: Dizziness, nausea, fever, body aches, joint pain, throbbing headache x 24 hours. Started at 9pm on the evening of the shot (12Jan2021) and symptoms ceased exactly 24 hours later. The outcome of the events was recovered on 13Jan2021 21:00. No treatment for the events.
Headache; Sore arm; Swelling of the feet; This is a spontaneous report from a contactable consumer (patient herself).  This 53-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unknown route, on 23Dec2020 at single dose for COVID-19 immunisation. She was working as a receptionist in a nursing home. Age at vaccination was 53-year-old. No relevant medical history and concomitant medications were provided. On unknown date after vaccination, the patient developed headache, sore arm, and swelling of the feet. The outcome of the events was unknown.  Information on the lot/batch number has been requested.
Start throwing up; Body ache; Headache; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (Body ache), HEADACHE (Headache) and VOMITING (Start throwing up) in a 57-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included VITAMIN D [VITAMIN D NOS], ASPIRIN [ACETYLSALICYLIC ACID], CHOLESTEROL and SITAGLIPTIN PHOSPHATE (JANUVIA [SITAGLIPTIN PHOSPHATE]) for an unknown indication.    On 15-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Mar-2021, the patient experienced MYALGIA (Body ache) and HEADACHE (Headache). On 19-Mar-2021, the patient experienced VOMITING (Start throwing up). At the time of the report, MYALGIA (Body ache), HEADACHE (Headache) and VOMITING (Start throwing up) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was provided.
Vomiting 10/21/02 1pm advised clear liquids cried x 14 minutes high pitched cry. Cried until she fell asleep 10/21/02 2pm spoke with mom 10/22/02 pt doing better no vomiting, no fever. Pt seen 10/25/02 with ear infection.
The evening after the injections I began to have had headache, severe joint pain, particularly in hip shoulder and knees. I had fever for about 4 days. Fever was never high, never got over 102.0. I took Tylenol. 1 week later I had an  odor under my arm. Odor lasted for about 5 to 6 weeks total. I was very tired and weak.
Information has been received from a newspaper reporter concerning an 11 year old female who in approx. 1991, at the age of 1, was vaccinated with a 1st dose of MMRII and in approx. 1995, at the age of 5, was vaccinated with a 2nd dose of MMRII. It was reported that in approx. 6/01, the pt started having trouble in school. Prior to that she was a good student. She developed some seizures in 6/01. She was dx'd with epilepsy and placed on therapy. The pt did well for several months. In approx. 9/01, she started getting sleepy, her speech became slurred and she did not respond very well. She was hospitalized for approx. 1 week with no dx being made. She was then transferred to another hospital where she had a 1 month hospitalization. Her work-up included a brain biopsy from which a dx of subacute sclerosing panencephalitis (SSPE) was made. It was reported that the pt's physician indicated the SSPE could have been due to an old measles infection or the the vaccine. At the time of this report, the pt was on experimental medication and was unable to walk, talk and feed herself. Additional information has been requested. A 15-day follow up report received 10/10/2002 adds: Follow-up received on 08/02/2002 reported that the brain biopsy tissue evaluated for measles virus. RTPCR and subsequent sequencing of the amplified region indicated that the child was infected with wild type measles virus. It was noted that this represents a case of wild type measles infection after primary vaccine failure. It was reported on 08/02/2002 that the pt expired "a few months ago". Additional info has been requested.
Patient's mother reported patient became clammy, sweaty, and dizzy several minutes after receiving vaccine.  Approximately 15 minutes after receiving vaccine, the patient's mother reported to the pharmacy that she wasn't feeling well.  The patient was seated when I was called over to check on her.  She was sweaty and reported that she was dizzy and had "heavy breathing" but no chest tightness.  After drinking some water and sitting for approximately 10 additional minutes, she said she was feeling better and her parents said they would keep an eye on her.  Parents reported at a later date that the patient was back to normal an hour later.
Information has been received from a health professional concerning a patient who was vaccinated with GARDASIL. Subsequently the patient experienced atrial arrhythmia and was scheduled to have ablation for correction of the arrhythmia could to be related to GARDASIL. There was no other information provided at this time and the health professional did not feel that this atrial arrhythmia was related to vaccination. This is one of several reports received from the same source. Additional information has been requested.
On 10/6 patient reported redness and swelling at ZOSTAVAX site. We followed up with the patient on 10/10 when she said she was feeling better but did have trouble breathing after injection. She also mentioned that she has "a lot of allergies" that she didn't report at time of vaccination.
Severe dizziness, nausea and vomiting on on two occasions lasting many hours and left hand tingling consistently and pain intermit-ant immediate after injection
Difficulty breathing, Right leg cramps, I contacted the doctor right away because I thought I was having a (DVT) Deep Vein Thrombosis and they sent me to the Emergency room and the first time I went there, they did not find anything but then I went for the 2nd time and they found the DVT on my right leg (mid calf area) and I was hospitalized, they prescribed me with Eliquis after 2 - 3 days the discomfort in my legs have improved but I was still coughing a lot so my doctor prescribed me with a Potassium Pill (Pot Chloride, Losartan), I have never had problems with my lungs and my heart until I got my 2nd dose vaccination.
Chills, Fever and extreme pain in urination with very little coming out for 4 or 5 days. Much higher Urinary Urgency this week than last week afer taking Zostavax Vaccine at Medical Center - Shingles Vaccine. Stop taking aspirin for the heart after 2nd day. Started Tylenol.
NOT AN ADVERSE EVENT.  Reporting procedural error only.   Unvaccinated 3YO child presented for first COVID-19 dose at  field clinic.  Child erroneously received 0.25mL from Moderna Bivalent vial for 6months-5years (Moderna Pink Vial).  Error was discovered immediately after injection.  This injection equalled an under-dose yielding only 12.5micrograms.  To remedy on the same day, another 0.25mL was administered from another Moderna Bivalent vial for 6months-5years (Moderna Pink Vial).  Child was observed for 15minutes after both injections and was released with no adverse reactions.  At telephone follow-up 1 week later, guardian stated that child only experienced the mild, expected side effects.  This type of error may be predisposed from current structure of vaccination schedule for children under 6years receiving Moderna Bivalent.  Reporting for surveillance and QI purposes.
She said that 3 weeks to the day after she had the J& J shot on 4/12/21 she woke up with a sore left outer leg and then the pain went away and moved to her chest and then moved to her head.  She wondered if she had a blood clot or was having a stroke and then the pain went away within a half an hour.
Information has been received from a physician concerning a 44 year old male patient with a history of seizures and whom the physician initially reported had symptoms of Bell's palsy and subsequently the physician reported had Bell's pals beginning a few days prior to vaccination. On 22MAY2003 the patient was vaccinated with a dose of measles virus vaccine live + mumps virus vaccine live + rubella virus vaccine live (second generation). Concomitant therapy included phenytoin. Subsequently the physician reported that the patient had Bell's palsy and it was unknown if the Bell's palsy worsened after vaccination with measles virus vaccine live + mumps virus vaccine live + rubella virus vaccine live. The physician saw the patient on 27MAY2003 and treatment was acyclovir. The physician reported that she wanted to prescribe steroids. The physician reported that she did not consider the Bell's palsy related to the measles virus vaccine live + mumps virus vaccine live + rubella virus vaccine live (second generation). Additional information has been requested.
Received flu shot on November 24, 2021 at approximately 12pm. Nurse gave the injection in my left arm and it was given maybe 2 fingers distance below the shoulder joint. Once received it instantly caused pain and the pain has not gone away after using over the counter pain relievers, massage, numbing medication. Causes pain while sleeping and wakes me up out if I lay on it the wrong way. Also tried ice and warm compress with no relief. Unsure if injection caused a freezing/locking in my arm/shoulder. Have had multiple flu shots in the past with no reaction.
On 1/14/00, the pt presented with chickenpox that consisted of "scattered pink papules including vesicles on neck, torso, and lower extremities, and a temperature of 104F." Medical intervention was required in the form of treatment with calamine, camphor, pramoxine hydrochloride (Aveeno). Additional information has been requested.
SEVERE VOMITING, CHILLS, SWEATS, WEAK, LIGHTHEADED, TIRED, THIS STARTED FIRST THING IN THE MORNING 10/30/2009, LASTED ALL DAY.  THE VOMITING SUBSIDED AROUND 6PM HOWEVER THE REMAINING SYMPTOMS LASTED UNTIL 11/3/2009
This spontaneous report was received from a nurse practitioner refers to a 1 month old female patient with none pertinent medical history, drug reactions or allergies. On 05-FEB-2013, the patient was vaccinated with RECOMBIVAX HB, 0.5 ml, intramuscular injection as prophylaxis (lot number not reported). Concomitant medication was not reported. On 05-FEB-2013, the patient exhibited significantly diminished suck response since administration of RECOMBIVAX HB. The patient was not treated. Laboratories test were not performed. The patient's mother called nurse practitioner office. At the time of the report, the outcome of significantly diminished suck response was reported as not recovered/not resolved. The event of significantly diminished suck response was unknown related to RECOMBIVAX HB. Additional information has been requested.
Red hot warm to touch. Hard lump under skin. 4 x 2 inches swollen area
pain in upper rt side, nausea, loss of appetite, extreme fatigue, fever, h/a, gen ill feeling, joint pain, yellow color-skin, eyes;dx hep A viral AB D-M non reactive;
Muscle ache; This case was reported by a consumer via (Shingrix GSK Chatbot) interactive digital media and described the occurrence of muscle pain in a patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced muscle pain. On an unknown date, the outcome of the muscle pain was unknown.   It was unknown if the reporter considered the muscle pain to be related to Shingrix.  Additional details were reported as follows: The patient self-reported this case. The age at vaccination was not reported. The patient inquired that it was okay to take Tylenol for muscle ache after the Shingrix vaccination. The follow up would not possible as contact information was not available.
Initial chest pain, sob and rapid heart rateand tightness and pain in back of head  afterwards. Could not get out of bed for 5 days following. The next week chest pain that radiates into back, neck, shoulder and  jaw with profuse sweating,  sob, dizziness,  blurred vision, swelling in fingers,  abdominal pain and nausea. Heart rate has consistently run between 122-168 and has been as high as 200bpm. Blood pressure 150/100. This worsens whenever I stand to do anything!!!!
had a temperature excursion where the highest the vials got was 10.6 degrees Celsius from about 7:30am-3:30pm; adminstered to patient / had a temperature excursion where the highest the vials got was 10.6 degrees Celsius from about 7:30am-3:30pm; This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT STORAGE ERROR (had a temperature excursion where the highest the vials got was 10.6 degrees Celsius from about 7:30am-3:30pm) and EXPIRED PRODUCT ADMINISTERED (adminstered to patient / had a temperature excursion where the highest the vials got was 10.6 degrees Celsius from about 7:30am-3:30pm) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 25-May-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 2 dosage form. On an unknown date, the patient experienced PRODUCT STORAGE ERROR (had a temperature excursion where the highest the vials got was 10.6 degrees Celsius from about 7:30am-3:30pm) and EXPIRED PRODUCT ADMINISTERED (adminstered to patient / had a temperature excursion where the highest the vials got was 10.6 degrees Celsius from about 7:30am-3:30pm). At the time of the report, PRODUCT STORAGE ERROR (had a temperature excursion where the highest the vials got was 10.6 degrees Celsius from about 7:30am-3:30pm) and EXPIRED PRODUCT ADMINISTERED (adminstered to patient / had a temperature excursion where the highest the vials got was 10.6 degrees Celsius from about 7:30am-3:30pm) outcome was unknown. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   The action taken with the drug was not applicable.   Most recent FOLLOW-UP information incorporated above includes: On 25-May-2021: NNI
Started with severe chills around 10:30pm. Proceeded to nausea, sweats, fever of 100.4F, headache, dizziness, and joint pain. Lasted about 16 hours. The headache and dizziness are still present. I?ve had a COVID test performed on 3/19/21 which was negative.
arm swollen from shoulder to wrist red, hot, hard to touch tx w/APAP & warm compresses 3x Friday-taken to MD advised to use cool compresses no cellulitis noted;mom then took to ER told rxn to vaccine;
Patient received their vaccine around 10 am on 8/11/21, and they reported they went to lunch and felt fine, then a few hours later they got back to work and their heart rate was elevated and they felt dizzy. Upon a follow-up call, they reported their heart rate was still 120-130bpm despite resting and relaxing and taking Benadryl.
Rash, body aches, fever (103 F). Symptomatic for 36 hours when left work to go to ER for treatment.  Treated at Health Center. Given Solu-Medrol, tylenol, two liters of saline, toradol, and benadryl.
Patient was administered dose #3 in Hepatitis B series on 2 JUL 14 at hospital. On 18 JUL, patient was notified by his work center at the that he "was due for a shot" and was again administered a dose of hepatitis B vaccine. Patient did not have any adverse events. Error was realized during an Occupational Health screening approximately 1 week after that.
Information regarding PREVNAR 13 was received from a nurse regarding a 3-year-old female patient who experienced local skin reaction involving redness and swelling of the whole right thigh. The patient received a dose on an unknown date in 2010. The patient experienced local skin reaction involving redness and swelling of the whole right thigh on an unknown date in 2010. The patient was brought back to the doctor's office because the area of swelling had gotten larger. BENADRYL was administered as treatment. The erythema and swelling resolved on an unknown date. No additional information was available at the time of this report.
PT HERE FOR 2ND DOSE OF MODERNA. NO TROUBLES WITH FIRST DOSE. PT REPORTS "COLDNESS IN MY LEFT HAND FOR 15 MIN". AFTER TAKING VITALS, REASSURING VSS, AND ANOTHER 15 MIN WAITING PERIOD, PT REPORTS TO SAFETY OFFICERS AND POST OBSERVATION MONITORS THAT "NO LONGER FEELING COLNESS IN MY HANDS." PT DENIES TROUBLES BREATHING, NO RASH PRESENT. PT REFUSED 2ND SE TOF VITALS AND LEFT FACILITY IN NO APPARENT DISTRESS.
Client was vaccinated with 2 doses of Pfizer vaccine for Covid in February 2021.  Had contact with son who was Covid + and then  client developed symptoms on 11/7 - cough, fatigue.  Tested + PCR on 11/8/2021.  Reported as a case of breakthrough Covid illness in a vaccinated person.
red arm; Sore arm where the shot was given; This case was reported by a consumer via sales rep and described the occurrence of injection site erythema in a 74-year-old patient who received Herpes zoster (Shingrix) for prophylaxis.   On 15th August 2019, the patient received the 1st dose of Shingrix. On an unknown date, less than 3 months after receiving Shingrix, the patient experienced injection site erythema and injection site pain. On an unknown date, the outcome of the injection site erythema and injection site pain were unknown.   It was unknown if the reporter considered the injection site erythema and injection site pain to be related to Shingrix.  Additional details were received as follows: The age at vaccination was not reported. The patient received Shingrix on left arm and experienced reactions that red and sore left arm where the shot was given. The reporter consented to follow up. This case has been linked with the case US2019AMR211822, for 2nd dose.
Significant bruise on leg  about 5cm in diameter initially   Still have faint bruise 2 weeks later.
Child was given Quadracel instead of Pentacel. Child showed no adverse reaction at the time of the vaccine.
The pt experienced severe hot, raised red and white rash with accompanied pain noticed upon awakening the following morning. Motrin was given 2 hours later at the doctors office.
Syncope, Dizziness, diapheretic, BP 98/56, P 58
Swelling; Burning at the injection site; Hives; This spontaneous case was received on 12-Nov-2020 from a nurse via Med Communications (reference number: SEQW20-05059) and concerned a 31-year-old, female patient.  The patient had no relevant medical history and was not taking any concomitant medications.  On 16-Oct-2020, the patient was vaccinated with Flucelvax QIV (influenza vaccine, subunit influenza virus vaccine polyvalent, dose; 0.5 ml, route of administration: intramuscular and anatomical location: not reported) for flu prevention. The batch number reported was 276539, and expiration date was reported as 14-Jun-2021.  On the same day, after receiving Flucelvax QIV, the patient experienced burning at the injection site, swelling and hives. The patient went to urgent care where she was told to take ice and Benadryl (diphenhydramine hydrochloride).  At the time of initial report on 12-Nov-2020, the patient was recovering from the events, and she was feeling better.  The reporter did not provide a causality assessment.  This case was assessed as non-serious.  This case is linked to a case 2020006297 (the same reporter).  Company comment: A 31-year-old, female patient was administered Flucelvax QIV. On the same day, soon after receiving vaccine, the patient experienced burning at the injection site, swelling and hives. The patient had no relevant medical history and was not taking any concomitant medications. Causal role of the suspect vaccine is assessed as possibly related for vaccination site pain, urticaria and swelling.; Sender's Comments: A 31-year-old, female patient was administered Flucelvax QIV. On the same day, soon after receiving vaccine, the patient experienced burning at the injection site, swelling and hives. The patient had no relevant medical history and was not taking any concomitant medications. Causal role of the suspect vaccine is assessed as possibly related for vaccination site pain, urticaria and swelling.
Pt had an exacerbation of her asthma a few hours after the PNEUMOVAX PPSV23 on 11/19/13. Pt return to clinic on 11/22/13 with wheezes and rhonchi. Pt tx with SOLU-MEDROL 125mg, BENADRYL 50mg and MEDROL.
Severe flu like symptom: Body aches, head aches, and fever that lasted upto 4 days following  the first and second shot of shingrex. Patient taking Acetaminophen to help with symptoms and to contact physcian.